Cargando…
48352 Mechanisms Underlying Lipidomic Changes in Major Depressive Disorder
ABSTRACT IMPACT: Lipidomics is emerging as a powerful strategy to identify biomarkers for Major Depressive Disorder, as well as therapeutic targets in lipid metabolic pathways. OBJECTIVES/GOALS: Lipidomics is increasingly recognized in precision psychiatry for global lipid perturbations in patients...
Autores principales: | Costa, Ana Paula, van Dijr, Milenna T., Talati, Ardesheer, Weissmann, Myrna M., McIntire, Laura Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828028/ http://dx.doi.org/10.1017/cts.2021.656 |
Ejemplares similares
-
Concordance in parent and offspring cortico-basal ganglia white matter connectivity varies by parental history of major depressive disorder and early parental care
por: Abraham, Eyal, et al.
Publicado: (2020) -
251 A Mixed Methods Study of Patient and Clinician Views and Experiences of Pharmacogenomic Testing for Major Depressive Disorder
por: Hendy, Katherine, et al.
Publicado: (2023) -
4292 Epigenetic Age and Depressive Symptoms in African American Women with Cardiometabolic Conditions
por: Perez, Nicole B, et al.
Publicado: (2020) -
27416 DNA Methylation Age Acceleration and Depressive Symptoms in African American Women with Cardiometabolic Conditions
por: Perez, Nicole, et al.
Publicado: (2021) -
4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
por: Nunez Medina, Hector Jose, et al.
Publicado: (2020)